Integration of genetics and MRD to define low risk patients with B-cell precursor acute lymphoblastic leukaemia with intermediate MRD levels at the end of induction.
Moorman AV, Enshaei A, Murdy D, Joy M, Boer JM, den Boer ML, Pieters R, de Haas V, Horstmann MA, Escherich G, Johansson B, Marquart HV, Schmiegelow K, Hancock J, Moppett J, Heyman M.
Moorman AV, et al. Among authors: den boer ml.
Leukemia. 2024 Sep;38(9):2023-2026. doi: 10.1038/s41375-024-02329-0. Epub 2024 Jul 5.
Leukemia. 2024.
PMID: 38965371
Free PMC article.
No abstract available.